Cargando…
A remote speech‐based AI system to screen for early Alzheimer's disease via smartphones
INTRODUCTION: Artificial intelligence (AI) systems leveraging speech and language changes could support timely detection of Alzheimer's disease (AD). METHODS: The AMYPRED study (NCT04828122) recruited 133 subjects with an established amyloid beta (Aβ) biomarker (66 Aβ+, 67 Aβ–) and clinical sta...
Autores principales: | Fristed, Emil, Skirrow, Caroline, Meszaros, Marton, Lenain, Raphael, Meepegama, Udeepa, Cappa, Stefano, Aarsland, Dag, Weston, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632864/ https://www.ncbi.nlm.nih.gov/pubmed/36348974 http://dx.doi.org/10.1002/dad2.12366 |
Ejemplares similares
-
Leveraging speech and artificial intelligence to screen for early Alzheimer’s disease and amyloid beta positivity
por: Fristed, Emil, et al.
Publicado: (2022) -
Validation of a Remote and Fully Automated Story Recall Task to Assess for Early Cognitive Impairment in Older Adults: Longitudinal Case-Control Observational Study
por: Skirrow, Caroline, et al.
Publicado: (2022) -
Protocol for Rhapsody: a longitudinal observational study examining the feasibility of speech phenotyping for remote assessment of neurodegenerative and psychiatric disorders
por: Hampsey, Elliot, et al.
Publicado: (2022) -
Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders (RHAPSODY): a study protocol
por: Taylor, R., et al.
Publicado: (2022) -
Validity and Cultural Generalisability of a 5-Minute AI-Based, Computerised Cognitive Assessment in Mild Cognitive Impairment and Alzheimer's Dementia
por: Kalafatis, Chris, et al.
Publicado: (2021)